Propanc Biopharma (PPCB) Cash Flow: Operating & Free Cash Flow

Propanc Biopharma Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Propanc Biopharma, Inc. (PPCB) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Jun 2026	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Sep 2019	Jun 2018	Jun 2017
Operating Activities
Net Income	-18.86	-58.92	-1.82	-2.66	-2.66	-2.03	-4.74	-5.76	-7.04	-7.87
Depreciation & Amortization	8.52	0.02	0.02	0.02	0.01	0.00	0.00	0.00	0.00	0.00
Stock Based Compensation	13.57	4.62	0.00	0.00	0.00	0.21	0.00	0.00	0.00	0.00
Change in Working Capital	-0.58	1.14	0.42	0.47	0.17	0.44	0.21	0.50	0.88	0.52
Change in Accounts Receivable	-0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02
Change in Accounts Payable	-0.18	0.19	0.24	0.08	0.02	0.18	-0.06	-0.16	0.73	0.15
Change in Other Working Capital	-0.39	0.95	0.18	0.39	0.15	-0.01	0.27	0.67	0.14	0.35
Other Operating Activities	5.24	52.74	0.45	1.06	1.05	0.23	2.68	3.19	3.98	5.19
Net Cash from Operating Activities	-5.68	-0.41	-0.94	-1.11	-1.44	-1.15	-1.85	-2.06	-2.18	-2.15
Investing Activities
Capital Expenditures	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.18	0.00
Net Cash from Investing Activities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financing Activities
Debt Repayment	-0.81	0.76	0.92	0.59	0.77	-0.04	1.47	1.03	2.40	1.74
Common Stock Issued	7.26	0.00	0.02	0.02	0.10	0.78	0.45	1.10	0.00	0.46
Dividends Paid	-0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Financing Activities	0.93	-0.26	0.72	0.50	0.63	0.78	-0.03	-0.02	0.00	0.00
Net Cash from Financing Activities	6.46	0.49	0.94	1.11	1.49	1.06	1.89	2.12	2.40	2.20
Summary
Effect of Forex Changes on Cash	0.05	-0.09	0.00	0.00	-0.05	0.02	0.00	0.00	0.00	0.00
Net Change in Cash	0.82	-0.01	0.01	0.01	0.00	-0.06	0.00	0.00	0.00	0.00
Cash at Beginning of Period	0.01	0.02	0.01	0.00	0.00	0.07	0.00	0.02	0.07	0.12
Cash at End of Period	0.83	0.01	0.02	0.01	0.00	0.00	0.07	0.00	0.02	0.07
Free Cash Flow	-5.69	-0.41	-0.94	-1.11	-1.44	-1.15	-1.85	-2.06	0.00	-2.15
Supplemental Disclosures
Interest Paid	-	0.03	0.01	0.00	0.00	0.01	-	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Propanc Biopharma Cash Flow

What is Propanc Biopharma's free cash flow?

Propanc Biopharma had negative free cash flow of $5.69M in fiscal 2026 (fiscal year ended Jun 30, 2026), operating cash flow of −$5.68M minus $4.93K of capital expenditures.

How much does Propanc Biopharma spend on capital expenditures?

Propanc Biopharma spent $4.93K on capital expenditures in fiscal 2026, compared with $2.00 a year earlier.

Does Propanc Biopharma pay dividends or buy back shares?

Yes. In fiscal 2026 Propanc Biopharma returned $932.25K in dividends to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition